| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LBRX | LB PHARMACEUTICALS INC | Chief Executive Officer, Director | Sep 10, 2025 | |||
| LYEL | Lyell Immunopharma, Inc. | Chief General Counsel | Mar 16, 2022 | |||
| TERN | Terns Pharmaceuticals, Inc. | Director | Jun 11, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|